FDA approves AstraZeneca’s immunotherapy for bladder cancer – Reuters
Reuters |
FDA approves AstraZeneca's immunotherapy for bladder cancer
Reuters FDA approves AstraZeneca's immunotherapy for bladder cancer. FILE PHOTO: The logo of AstraZeneca is seen on a medication package at a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo. The U.S. Food and Drug Administration … |
